Enliven Therapeutics, Inc. - Common Stock, $0.001 par value per share (ELVN)

Q: What does CUSIP 29337E102 represent in this 13F holders report?

CUSIP 29337E102 is the security identifier for ELVN - Enliven Therapeutics, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held ELVN - Enliven Therapeutics, Inc. - Common Stock, $0.001 par value per share in Q3 2025?

132 institutional investors reported ELVN - Enliven Therapeutics, Inc. - Common Stock, $0.001 par value per share for Q3 2025. Use the holders table for investor-level position and value details.

CUSIP: 29337E102

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 59,773,132
Total 13F shares: 59,389,507
Share change: -50,833
Total reported value: $1,215,687,864
Price per share: $20.47
Number of holders: 132
Value change: -$296,366
Number of buys: 77
Number of sells: 42

Security key

29337E102

Report period

Q3 2025

Institutions

132

Top holders

ELVN full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2025 Previous quarter: Q2 2025 Enliven Therapeutics, Inc. SEC filings Enliven Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 29337E102

Newer quarter: Q4 2025 Previous quarter: Q2 2025

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top shareholders of ELVN - Enliven Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

ORBIMED ADVISORS LLC

13D/G signal

ORBIMED ADVISORS LLC

Evidence rows

Latest as of

30 Sep 2025

3/4/5 13D/G 13F Lead comparable stake: 13% 13D/G row: ORBIMED ADVISORS LLC Showing first 8 of 50 holder rows. Open remaining rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	3/4/5 13D/G 13F Director, 10%+ Owner · Company 3/4/5 13D/G 13F	13% from 13D/G	$169,666,547 7,663,349 shares	—	16 May 2024
FMR LLC	13D/G 13F Company 13D/G 13F	13%	$161,103,383 7,870,219 shares	$0	30 Sep 2025
BlackRock, Inc.	13F 13D/G Company 13F 13D/G	5.1% from 13D/G	$59,520,706 2,967,134 shares	—	30 Jun 2025
Commodore Capital LP	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	7.9%	$94,137,749 4,692,809 shares	—	30 Jun 2025
Venrock Adviser, LLC	13F Company 13F	6.7%	$80,768,200 4,026,331 shares	—	30 Jun 2025
Fairmount Funds Management LLC	13F Company 13F	6.2%	$74,451,567 3,711,444 shares	—	30 Jun 2025
Polar Capital Holdings Plc	13F Company 13F	5.1%	$61,188,898 3,050,294 shares	—	30 Jun 2025
VANGUARD GROUP INC	13F Company 13F	4%	$48,357,358 2,410,636 shares	—	30 Jun 2025

Show 42 additional holder rows in the full holder list

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
JANUS HENDERSON GROUP PLC	13F Company 13F	2.9%	$34,414,061 1,716,412 shares	—	30 Jun 2025
CITADEL ADVISORS LLC	13F Company 13F	2.5%	$29,496,705 1,470,424 shares	—	30 Jun 2025
Point72 Asset Management, L.P.	13F Company 13F	2.3%	$27,142,739 1,353,078 shares	—	30 Jun 2025
Blackstone Inc.	13F Company 13F	2.2%	$26,491,076 1,320,592 shares	—	30 Jun 2025
Capital Research Global Investors	13F Company 13F	2.2%	$26,388,228 1,315,465 shares	—	30 Jun 2025
Woodline Partners LP	13F Company 13F	1.8%	$22,079,179 1,100,657 shares	—	30 Jun 2025
Novo Holdings A/S	13F Company 13F	1.8%	$21,753,706 1,084,432 shares	—	30 Jun 2025
Pictet Asset Management Holding SA	13F Company 13F	1.6%	$19,408,090 967,502 shares	—	30 Jun 2025
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	1.5%	$17,710,667 882,753 shares	—	30 Jun 2025
RA CAPITAL MANAGEMENT, L.P.	3/4/5 13F Former 10% owner · Company 3/4/5 13F	1.4% from 13F	$32,123,508 2,122,465 shares	—	23 Feb 2023
STATE STREET CORP	13F Company 13F	1.4%	$16,373,815 816,242 shares	—	30 Jun 2025
5AM Venture Management, LLC	13F Company 13F	1.3%	$15,495,889 772,477 shares	—	30 Jun 2025
Rock Springs Capital Management LP	13F Company 13F	1.2%	$14,070,244 701,408 shares	—	30 Jun 2025
PRICE T ROWE ASSOCIATES INC /MD/	13F Company 13F	0.88%	$10,597,000 528,250 shares	—	30 Jun 2025
First Turn Management, LLC	13F Company 13F	0.85%	$10,230,339 509,987 shares	—	30 Jun 2025
TCG Crossover Management, LLC	13F Company 13F	0.83%	$9,989,880 498,000 shares	—	30 Jun 2025
Duquesne Family Office LLC	13F Company 13F	0.77%	$9,288,000 463,000 shares	—	30 Jun 2025
FRANKLIN RESOURCES INC	13F Company 13F	0.72%	$8,630,614 430,240 shares	—	30 Jun 2025
S.c.a. Candriam	13F Individual 13F	0.7%	$8,358,355 416,650 shares	—	30 Jun 2025
Affinity Asset Advisors, LLC	13F Company 13F	0.67%	$8,024,000 400,000 shares	—	30 Jun 2025
Logos Global Management LP	13F Company 13F	0.59%	$7,021,000 350,000 shares	—	30 Jun 2025
MARSHALL WACE, LLP	13F Company 13F	0.56%	$6,686,660 333,333 shares	—	30 Jun 2025
NORTHERN TRUST CORP	13F Company 13F	0.54%	$6,512,039 324,628 shares	—	30 Jun 2025
MILLENNIUM MANAGEMENT LLC	13F Company 13F	0.53%	$6,388,087 318,449 shares	—	30 Jun 2025
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F Company 13F	0.51%	$6,131,540 305,660 shares	—	30 Jun 2025
Ally Bridge Group (NY) LLC	13F Company 13F	0.47%	$5,644,764 281,394 shares	—	30 Jun 2025
MORGAN STANLEY	13F Company 13F	0.43%	$5,112,260 254,848 shares	—	30 Jun 2025
Vestal Point Capital, LP	13F Company 13F	0.42%	$5,015,000 250,000 shares	—	30 Jun 2025
Patient Square Capital LP	13F Company 13F	0.41%	$4,931,510 245,838 shares	—	30 Jun 2025
Cormorant Asset Management, LP	13F Company 13F	0.33%	$4,012,000 200,000 shares	—	30 Jun 2025
GOLDMAN SACHS GROUP INC	13F Company 13F	0.32%	$3,801,470 189,505 shares	—	30 Jun 2025
HighVista Strategies LLC	13F Company 13F	0.24%	$2,838,811 141,516 shares	—	30 Jun 2025
UBS Group AG	13F Company 13F	0.23%	$2,773,897 138,280 shares	—	30 Jun 2025
SPHERA FUNDS MANAGEMENT LTD.	13F Company 13F	0.22%	$2,578,011 128,515 shares	—	30 Jun 2025
BAKER BROS. ADVISORS LP	13F Company 13F	0.19%	$2,303,550 114,833 shares	—	30 Jun 2025
Bank of New York Mellon Corp	13F Company 13F	0.16%	$1,968,468 98,129 shares	—	30 Jun 2025
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F Company 13F	0.16%	$1,925,760 96,000 shares	—	30 Jun 2025
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	0.16%	$1,885,881 94,012 shares	—	30 Jun 2025
Nuveen, LLC	13F Company 13F	0.15%	$1,799,622 89,712 shares	—	30 Jun 2025
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F Company 13F	0.14%	$1,666,063 83,054 shares	—	30 Jun 2025
BARCLAYS PLC	13F Company 13F	0.12%	$1,460,046 72,784 shares	—	30 Jun 2025
ROYAL BANK OF CANADA	13F Company 13F	0.11%	$1,361,000 67,862 shares	—	30 Jun 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

132

59,389,507

Rows loaded

132

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

123

Q3 2025 holders

132

Holder diff

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 value	Q3 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend